Myeloma Canada is committed to supporting prioritized, clinically relevant research projects that correspond to, and further, our mission. Projects in which we invest, identify, and address knowledge gaps in the diagnosisThe process of identifying a disease by its signs and symptoms., treatment, and science of myeloma and related plasma cell disorders, with the goal of improving quality of life and ultimately, finding a cure.
While some projects may be conducted regionally, the research impact must benefit the national or international myeloma community.
Building hope through research: Myeloma Canada research principles
As a grassroots organization, our research investment principles are anchored in the core values that support the priorities identified by our myeloma community. Myeloma Canada research grants fund Canadian research projects that satisfy one or more of Myeloma Canada’s Funded Research Principles & Priorities.
The research must have a direct impact on:
improving the quality of life and/or survival of myeloma patients;
increasing patient access to new myeloma therapies, new treatment combinations, or improved treatment administration;
improving myeloma healthcare delivery.
Patient involvement in the development of research protocols is an asset. Research that addresses at least one of the top 10 priorities for multiple myeloma research in Canada is strongly recommended.
See the impact of your investment in myeloma research.
Aldo Del Col Research Grant
To honour the legacy and memory of Myeloma Canada’s co-founder, the Aldo Del Col Research Grant funds patient-prioritized Canadian research projects that help address the knowledge gaps in the diagnosis and treatment of myeloma and/or related plasmaThe liquid part of the blood in which red blood cells, white blood cells, and platelets are suspended. cellThe basic unit of any living organism. disorders that were identified through the Myeloma Priority Setting Partnership (PSP).
The Myeloma PSP was a collaborative project between the Horizon Health Network, the Maritime SPOR SUPPORT UNIT (MSSU), and Myeloma Canada, and adhered to established PSP practices set by the James Lind Alliance.
To learn more about the winners partners and corresponding projects, click here.
Read the top 10 priority questions within the published correspondence, “The future of myeloma research in Canada and beyond: results of a James Lind Alliance priority setting partnership.”
Research proposals must:
be for projects of a duration of one or two years;
address one or more of the top ten priorities for multiple myeloma research in Canada as identified through the Myeloma PSP. Click here to access the Top 10 Myeloma Research Priorities;
satisfy one or more of Myeloma Canada’s Funded Research Principles. The research in question must have a direct impact on:
- improving the quality of life and/or survival of myeloma patients;
- increasing patient access to new myeloma therapies, new treatment combinations, or improved treatment administration;
- improving myeloma healthcare delivery.
Funded research projects will ideally have an impact on all Canadians impacted by myeloma. While some projects may be conducted regionally, the potential research impact should be applicable to the regional, provincial, or national myeloma community. Patient involvement in the planning, development, and execution of research projects is an asset. Research proposals are peer-reviewed by an Independent Research Review Committee (IRRC).
Indirect costs of research (e.g., institutional overhead, pooled costs, G&A, M&A, utilities, maintenance) are not permitted.
2024 Aldo Del Col Research Grants
Based on the number and quality of applications, grants totaling at least CDN $350,000 are expected to be awarded in 2024. The minimum award is CDN $50,000 and the maximum award is CDN $150,000. The IRRC will endeavour to award at least 1 grant in each of the following research categories:
- Accelerate the development of academic cellular therapies
- Lab/bench projects (including but not limited to the development of novel therapeutics)
- Quality of life, database or real-world evidence
- Clinical trialResearch studies done with patients to evaluate new treatments or new ways of combining and administering existing treatments. By testing new drugs or combinations of drugs, each study is designed to find better ways to treat the disease, as well as improve quality of life and answer scientific and clinical questions. The overall goal of conducting clinical trials is to improve patient care and outcomes. research components (e.g., quality of life or health economic analyses)